Broncho-Vaxom for children 10 capsules

Tradename:

Broncho-Vaxom

Compound:

Each capsule contains:

standardized lyophilisate of bacterial lysates (Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus viridans, Streptococcus pyogenes, Klebsiella pneumoniae, Klebsiella ozaenae, Staphylococcus aureus, Moraxella catarrhalis) 3.5 mg

Auxiliary components: anhydrous propyl gallate (E310); sodium glutamate; mannitol; pregelatinized starch; magnesium stearate; mannitol capsule shell: dye indigo carmine (indigotin) (E132); titanium dioxide (E171), gelatin.

Properties:

Immunostimulating drug of bacterial origin. Causes an immune response of the mucous membrane of the digestive tract. Especially the effect is manifested in Peyer's patches (PB) of the small intestine. Antigen-presenting cells (APC) in PB are activated by the drug and subsequently stimulate the cells responsible for specific immunity. When using the drug, an increase in the number of circulating B-lymphocytes is observed.

After stimulation of B-lymphocytes, there is an increase in the production of polyclonal antibodies, especially serum IgG and IgA secreted by the respiratory mucosa and saliva.

These antibodies are the first line of defense against a range of infectious agents (viruses and bacteria).

The drug has a powerful stimulating effect on most types of leukocytes, as evidenced by an increase in the number of myeloid and lymphoid cells, as well as a selective increase in the expression of receptors on their surface. Taken together, these data confirm that the drug triggers biological reactions that enhance the body's immune defense against infections.

Clinically, Broncho-Vaxom® for children reduces the frequency of acute respiratory tract infections, reduces the duration of their course, reduces the likelihood of exacerbations of chronic bronchitis, and also increases the body's resistance to infections of the respiratory system. This reduces the need for the use of other drugs, especially antibiotics.

Indications:

The drug is used in children from 6 months to 12 years of age according to the following indications:

– prevention of recurrent respiratory infections and exacerbations of chronic bronchitis;

-complex treatment of acute respiratory tract infections.

Dosage and administration:

inside.

Treatment: 1 caps. Broncho-Vaxom® for children daily in the morning on an empty stomach until the symptoms disappear, but not less than 10 days. If it is necessary to conduct antibiotic therapy with Broncho-Vax® for children, it should be taken in combination with an antibiotic from the beginning of treatment.

The duration of treatment or the appointment of a second course of therapy should be determined by the doctor, based on the state of health of the patient.

Prevention of exacerbations and maintenance therapy: 1 caps. Broncho-Vaxom® for children daily in the morning on an empty stomach. The course includes 3 cycles, each of which consists of a daily intake of 1 caps. within 10 days, the interval between cycles is 20 days.

If the capsule is difficult to swallow, it should be opened and the contents mixed with a drink (including fruit juice, milk).

Contraindications:

Hypersensitivity to the components of the drug.

Precautionary measures:

Broncho-Vaxom® for children should not be used in children under the age of 6 months.

To avoid overdose, do not use the drug in the form of capsules intended for adults (Broncho-Vaxom® adult, capsules, 7 mg).

The components of the drug may cause hypersensitivity reactions.

In case of persistent gastrointestinal disturbances, skin reaction, respiratory disorders or other symptoms of drug intolerance, treatment should be discontinued, because. These symptoms are manifestations of allergic reactions.

Side effects:

From the gastrointestinal tract: often – diarrhea, abdominal pain; unknown – vomiting, nausea.

From the nervous system: unknown – headache.

On the part of the respiratory system, chest and mediastinal organs: often – cough.

From the side of the skin and subcutaneous tissue: often – rash; unknown – urticaria, Quincke’s edema.

General disorders and disorders at the injection site: unknown – fever, fatigue.

On the part of the immune system: infrequently – hypersensitivity (erythematous rash, generalized rash, erythema, eyelid edema, facial edema, peripheral edema, facial swelling, itching, generalized itching, shortness of breath).

Storage method:

At a temperature not higher than 30 degrees.

Package:

The carton contains 30 capsules.